Intermediate-term intravenous therapy: a pilot study.
Midline catheters provide an effective alternative for intermediate-term intravenous therapy. During a pilot study, 27 midline catheters were inserted in patients who met specific criteria. The insertion success rate was 64%, and the infection rate was 7%. One mechanical phlebitis occurred, but it was resolved by the application of warm, moist heat. One chemical phlebitis occurred during antibiotic therapy. The average dwell time was 8.7 days, and the longest dwell time was 49 days. Patients reported the catheters to be very comfortable and did not experience limitations in mobility.